Instrument Inactif

Autres langues IGI LABORIGI Nyse

Actions

Cours en clôture Nyse Autres places de cotation
- ^USD	-

2022	Teligent, Inc. a fait faillite	CI
2022	Deuxième motion pour la prolongation de la période d'exclusivité approuvée pour Teligent, Inc.	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Hikma's diversified business delivers resilient H1 performance	05/08/22
Teligent, Inc. Went Out of Business	26/07/22
Second Amended Liquidation Plan Approved for Teligent, Inc.	15/07/22
Second Motion for Exclusivity Period Extension Approved For Teligent, Inc.	25/05/22
Second Amended Joint Liquidation Plan Filed by Teligent, Inc.	24/05/22
First Amended Disclosure Statement Approved for Teligent, Inc.	29/04/22
First Amended Joint Liquidation Plan and Disclosure Statement Filed by Teligent, Inc.	27/04/22
Joint Liquidation Plan and Disclosure Statement Filed by Teligent, Inc.	08/04/22
First Motion for Exclusivity Period Extension Approved For Teligent, Inc.	01/03/22
Motion for Case Conversion Filed by Teligent, Inc.	23/02/22
First Motion for Exclusivity Period Extension Filed by Teligent, Inc.	10/02/22
Hikma Pharmaceuticals Closes $46 Million Purchase of Teligent's Canadian Assets	03/02/22
Pharmaceutical Associates, Inc. completed the acquisition of Generic and Branded US Marketing Authorizations of Teligent, Inc. (OTCPK:TLGT.Q).	03/02/22
Hikma Pharmaceuticals PLC completed the acquisition of Canadian assets of Teligent Inc from Teligent, Inc. (OTCPK:TLGT.Q).	03/02/22
Motion for Asset Sale Approved for Teligent, Inc.	19/01/22
Motion for Asset Sale Approved for Teligent, Inc.	19/01/22
Motion for Asset Sale Approved for Teligent, Inc.	19/01/22
Hikma expands into Canada with acquisition of Teligent sterile injectable assets	18/01/22
London Shares to Open Higher as Traders Focus On Key Data	17/01/22
Hikma Pharmaceuticals to Enter Canadian Market With $46 Million Asset Acquisition	17/01/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues IGI LABORIGI Nyse

Actions

Autres langues

Filtres